Related Experiment Video
Updated: Jul 4, 2025

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.6K
A primer on formulary structures and strategies
1Cencora, Conshohocken, PA.
Journal of Managed Care & Specialty Pharmacy
|February 3, 2024
Summary
Formularies manage healthcare costs and improve patient outcomes by guiding therapy choices. Evolving strategies adapt to new products and health equity goals, ensuring sustainable managed care pharmacy.
Area of Science:
- Health Services Research
- Pharmaceutical Policy
- Managed Care Pharmacy
Background:
- Formularies are essential tools for managing healthcare costs, optimizing patient access to medications, and enhancing overall health outcomes.
- They aim to balance appropriate therapy access with effective resource utilization for sustainable managed care operations.
- Traditional formulary models include open, closed, and tiered structures, with newer approaches emphasizing product value.
Purpose of the Study:
- To review the role and evolution of formularies in managed care pharmacy.
- To identify key drivers and considerations in formulary development and customization.
- To explore emerging trends impacting future formulary strategies.
Main Methods:
- Review of existing formulary strategies and management principles.
- Analysis of factors influencing formulary design, including member populations and regulatory requirements.
- Discussion of the impact of new pharmaceutical products and health trends on formulary management.
Main Results:
- Formularies remain critical for managed care organizations, especially with the increasing prevalence of high-cost and specialty medications.
- Customized formulary development is influenced by diverse factors like regional needs and benefit designs.
- The formulary development process is guided by Pharmacy and Therapeutics (P&T) and value committees.
Conclusions:
- Formularies are dynamic tools that require continuous adaptation to market changes and healthcare priorities.
- Future formulary strategies will be shaped by innovations such as biosimilars, digital therapeutics, and a focus on health equity.
- Effective formulary management is crucial for achieving both cost-efficiency and optimal patient care in managed care settings.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
733
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
733
Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Insulin Formulations: Types and Delivery
197
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
197
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Factors Influencing Drug Absorption: Presystemic Elimination
219
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
219

